Holen Sie sich die Stockscreener-App
1.64
0.61%
0.01
Handel nachbörslich:
1.68
0.04
+2.44%
Schlusskurs vom Vortag:
$1.63
Offen:
$1.63
24-Stunden-Volumen:
109.69K
Relative Volume:
0.10
Marktkapitalisierung:
$9.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+7.89%
1M Leistung:
+7.89%
6M Leistung:
-75.52%
1J Leistung:
-82.27%
1-Tages-Spanne:
$1.59
$1.71
1-Wochen-Bereich:
$1.45
$1.71
52-Wochen-Spanne:
$0.97
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
Firmenname
Traws Pharma Inc
Sektor
Branche
Telefon
267-759-3680
Adresse
12 PENNS TRAIL, NEWTOWN
Vergleichen Sie TRAW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
1.64 | 9.07M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-01 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-05-18 | Eingeleitet | Guggenheim | Buy |
| 2018-03-01 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-17 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-04-27 | Eingeleitet | Laidlaw | Buy |
| 2015-07-01 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Traws Pharma Inc Aktie (TRAW) Neueste Nachrichten
How to integrate Traws Pharma Inc. into portfolio analysis toolsMarket Growth Report & Community Consensus Stock Picks - Newser
Best data tools to analyze Traws Pharma Inc. stock2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
What machine learning models say about Traws Pharma Inc.July 2025 Weekly Recap & Fast Gain Stock Trading Tips - Newser
How to build a custom watchlist for Traws Pharma Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
Institutional scanner results for Traws Pharma Inc. [Quarterly Trade Review]Stock Portfolio Risk Control - Newser
How Traws Pharma Inc. stock performs during market volatilityTechnical Analysis of Growth Stock Opportunities - Newser
How to monitor Traws Pharma Inc. with trend dashboardsAlgorithmic Forecast for Swing Trading Picks - Newser
How to use a screener to detect Traws Pharma Inc. breakoutsNeural Network Based Equity Prediction System - Newser
Can machine learning forecast Traws Pharma Inc. recovery5-Year Price Trend Summary and Analysis - Newser
Using Python tools to backtest Traws Pharma Inc. strategiesQuick Profit Setup with Signal Forecast - Newser
Traws Pharma TRAW 2025Q2 Earnings Preview Upside Potential on Expected Revenue Growth - AInvest
Using R and stats models for Traws Pharma Inc. forecastingFree Investment Strategy With Predictable Gains - Newser
Watch for Bullish Crossover in Traws Pharma Inc.Consistent Profit Pattern Recognition Tools Shared - metal.it
Can Traws Pharma Inc. stock recover from recent declineBuy Opportunity Forecast for Fast Traders - Newser
Intraday pattern recognizer results for Traws Pharma Inc.Capital Growth Plan for New Investors - Newser
Traws Pharma to Announce Q2 Results and Business Update on August 14 - MSN
Is Traws Pharma Inc. stock a value trapCapital Doubling Stock Strategy - kangso.co.kr
What makes Traws Pharma Inc. stock price move sharplyConsistent Gain Plan with AI Support - Newser
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewswire
Traws Pharma Earnings: Respiratory Viral Disease Pioneer Reports Q2 Results Next Week - Stock Titan
Can Traws Pharma Inc. Outperform Peers After Recent PullbackSwing Trading Plan With Smart Signals in Review - beatles.ru
Drawdown in Traws Pharma Inc. May Be Nearing EndAI Forecast Accuracy Evaluation Insight - beatles.ru
What catalysts could drive Traws Pharma Inc. stock higher in 2025High-yield investments - Jammu Links News
How strong is Traws Pharma Inc. company’s balance sheetTap into rapid wealth building techniques - Jammu Links News
Is Traws Pharma Inc. a good long term investmentUnlock exclusive trading strategies for gains - Jammu Links News
Why is Traws Pharma Inc. stock attracting strong analyst attentionSuperior trading gains - Jammu Links News
Does Traws Pharma Inc. stock perform well during market downturnsLightning-fast growth - Jammu Links News
What are Traws Pharma Inc. company’s key revenue driversFree Risk Assessment Services - Jammu Links News
How does Traws Pharma Inc. compare to its industry peersCapitalize on high-growth stocks early - Jammu Links News
What is Traws Pharma Inc. company’s growth strategyExceptional earning trajectories - Jammu Links News
What is the dividend policy of Traws Pharma Inc. stockHigh-yield capital appreciation - Jammu Links News
What institutional investors are buying Traws Pharma Inc. stockDiscover stock picks with superior returns - Jammu Links News
What markets is CORT expanding into Is Traws Pharma Inc. stock a good long term investment optionFree Buy/Sell Signal Notifications - Jammu Links News
What analysts say about Traws Pharma Inc. stockInvest in stocks with strong fundamentals - Jammu Links News
What are the latest earnings results for Traws Pharma Inc.Breakout portfolio performance - Jammu Links News
Is Traws Pharma Inc. a growth stock or a value stockExceptional market performance - Jammu Links News
When is Traws Pharma Inc. stock expected to show significant growthConsistently superior profits - Jammu Links News
Exit strategy if you’re trapped in Traws Pharma Inc.Stock Forecast Tools for Retail Traders - Newser
Institutional scanner results for Traws Pharma Inc.Weekly Hot Stocks Based on Volume Flow - Newser
How many analysts rate Traws Pharma Inc. as a “Buy”Top Growth Alerts For Smart Trading - Jammu Links News
Finanzdaten der Traws Pharma Inc-Aktie (TRAW)
Es liegen keine Finanzdaten für Traws Pharma Inc (TRAW) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):